Advisor Group’s CervoMed CRVO Stock Holding History

Advisor Group’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	13	–	–	﹤0.01%	5327
2019 Q3	$2K	Hold	13	–	–	﹤0.01%	4951
2019 Q2	$3K	Hold	13	–	–	﹤0.01%	4845
2019 Q1	$3K	Buy	+13	New	+$3.12K	﹤0.01%	4830
2018 Q4	–	Sell	-4	Closed	-$2K	–	5120
2018 Q3	$2K	Hold	4	–	–	﹤0.01%	4837
2018 Q2	$2K	Hold	4	–	–	﹤0.01%	4655
2018 Q1	$2K	Buy	4 +2	+100%	+$1.73K	﹤0.01%	4672
2017 Q4	$3K	Sell	2 -2	-50%	-$3.24K	﹤0.01%	4560
2017 Q3	$7K	Hold	4	–	–	﹤0.01%	4124
2017 Q2	$10K	Hold	4	–	–	﹤0.01%	3908
2017 Q1	$17K	Buy	4 +2	+100%	+$8.59K	﹤0.01%	3459
2016 Q4	$4K	Buy	+2	New	+$6.73K	﹤0.01%	4002

Other funds holding CRVO

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Advisor Group's CRVO Position: Q4 2019 in Review

Advisor Group held its CervoMed (CRVO) position steady in Q4 2019 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5327.

Advisor Group first reported a position in CRVO in Q4 2016 and has held it in 12 quarters since. The position peaked at $17K in Q1 2017. 18 funds tracked by Wall St. Rank hold CRVO as of Q4 2019.

Advisor Group held 13 shares of CervoMed worth $0 as of Q4 2019.
Advisor Group left its CervoMed share count unchanged in Q4 2019.
CervoMed made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5327 holding.
Advisor Group first reported a position in CervoMed in Q4 2016 and has held it in 12 quarters since.
Advisor Group's CervoMed position peaked at $17K in Q1 2017.
18 funds tracked by Wall St. Rank held CervoMed as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.